关于这篇文章的分析:洞察皮肤冠状动脉干预和跨导管大动脉置换的最佳时间
Bhushan Sandeep1, Fenglin Jiang2, Mingming Wang1
1Department of Cardio-Thoracic Surgery, Chengdu Second People's Hospital, Chengdu, Sichuan, P.R. China.
Current problems in cardiology
|September 23, 2023
概括
通过导管的大动脉置换 (TAVR) 为严重的大动脉狭窄提供了一个微创的选择,与医学治疗相比,死亡率降低. TAVR与外科门置换相似,每个手术都有不同的并发症概况.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 严重的症状性大动脉狭窄症 (AS) 需要干预.
- 过导管大动脉置换 (TAVR) 是对外科大动脉置换 (SAVR) 的最小侵入性替代方案.
- 与药物治疗相比,TAVR已经显示出显著的死亡率降低,并且在中高风险患者中,它与SAVR不逊色或优于SAVR.
研究的目的:
- 为了比较TAVR和SAVR的结果和并发症,在中等或更高的外科风险的严重症状AS患者中.
- 确定与TAVR相关的风险因素,特别是那些预测准膜泄漏 (PVL) 的风险因素.
主要方法:
- 对接受TAVR和SAVR治疗重症症状AS的患者的临床数据的审查.
- 对手术并发症的分析,包括血管并发症,PVL,新发性心房动,急性损伤和出血.
- 多变量分析以确定TAVR患者PVL的预测因子,包括环大小,TAVR前的跨膜Vmax和大动脉结石化.
主要成果:
- 在中高风险AS患者中,TAVR和SAVR的疗效相似.
- 血管并发症和PVL在TAVR后更频繁.
- 新发性心房动,急性损伤和危及生命的出血在SAVR后更为常见.
- 大动脉结石化是TAVR后PVL的独立预测因素.
结论:
- 在中高风险患者中,TAVR是一种可行的,有效的治疗严重症状性AS,其结果与SAVR相似.
- 了解TAVR和SAVR的不同并发症概况对于患者的选择和管理至关重要.
- 大动脉结石化是TAVR后PVL的重要风险因素,需要进一步调查和潜在的缓解策略.
更多相关视频
06:59Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
10.6K
09:57Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
Published on: January 20, 2022
2.7K
相关概念视频
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...